Rhokinase Inhibitors novel Potential Treatment Modality for Glaucoma

Rhokinase inhibitors is a new class of drug under trial that improve the outflow facility through conventional path way by inhibiting the contractile tone of actin cytoskeleton. They additionally protect trabecular meshworkfrom oxidative stress, improve Optic Nerve head blood flow, facilitate cornea...

Full description

Saved in:
Bibliographic Details
Main Author: Jasleen Dhillon
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-04-01
Series:Delhi Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.7869/djo.189
Tags: Add Tag
No Tags, Be the first to tag this record!